$LCID
Lucid Group, Inc. Stock $lcid

$lcid Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000162828022020609 Filed on August 03, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$195.5M	$97.34M	$57.68M
YoY Change	84148.71%	55840.23%	18326.52%
Cost Of Revenue	$492.5M	$292.3M	$246.0M
YoY Change	14733.83%	1538542.11%	289276.47%
Gross Profit	-$297.0M	-$195.0M	-$188.3M
YoY Change	9518.72%	-125910.32%	-82685.53%
Gross Profit Margin	-151.96%	-200.34%	-326.48%
Selling, General & Admin	$176.7M	$163.8M	$223.2M
YoY Change	-29.74%	126.66%	69.51%
% of Gross Profit
Research & Development	$213.8M	$200.4M	$186.1M
YoY Change	-11.82%	13.34%	11.18%
% of Gross Profit
Depreciation & Amortization	$50.65M	$42.45M	$38.24M
YoY Change	239.95%	522.5%	677.43%
% of Gross Profit
Operating Expenses	$390.5M	$364.2M	$409.2M
YoY Change	-20.95%	64680.66%	36.86%
Operating Profit	-$687.5M	-$559.2M	-$597.5M
YoY Change	38.32%	124.65%	99.98%
Interest Expense	$7.613M	$7.189M	$7.705M
YoY Change	9917.11%	23863.33%	154000.0%
% of Operating Profit
Other Income/Expense, Net	$157.6M	$338.8M	$516.6M
YoY Change	-676.53%	-2746.79%	-215.01%
Pretax Income	-$530.0M	-$220.4M	-$80.96M
YoY Change	1.06%	-15.8%	-89.18%
Income Tax	$100.0K	$68.00K	$300.0K
% Of Pretax Income
Net Earnings	-$530.1M	-$220.4M	-$81.29M
YoY Change	1.09%	-15.78%	-89.13%
Net Earnings / Revenue	-271.21%	-226.46%	-140.94%
Basic Earnings Per Share	-$0.32	-$0.13	-$0.05
Diluted Earnings Per Share	-$0.40	-$0.33	-$0.36
COMMON SHARES
Basic Shares Outstanding	1.673B shares	1.669B shares	1.654B shares
Diluted Shares Outstanding	1.691B shares	1.687B shares	1.682B shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.342B	$4.294B	$5.392B
YoY Change	-30.33%	668.94%	565.26%
Cash & Equivalents	$1.264B	$3.157B	$5.392B
Short-Term Investments	$2.078B	$1.137B
Other Short-Term Assets	$69.01M	$69.11M	$95.49M
YoY Change	241.4%	1.83%	86.6%
Inventory	$685.3M	$553.0M	$333.9M
Prepaid Expenses	$57.26M	$48.96M	$42.33M
Receivables	$2.659M	$1.294M	$867.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.156B	$4.966B	$5.864B
YoY Change	-16.65%	296317.79%	575.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.166B	$1.814B	$1.494B
YoY Change	124.26%	78.78%	66.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$513.7M	$278.1M
YoY Change
Other Assets	$51.49M	$71.23M	$43.24M
YoY Change	20.59%	81.39%	38.3%
Total Long-Term Assets	$2.731B	$2.163B	$1.537B
YoY Change	137.02%	4.47%	65.1%
TOTAL ASSETS
Total Short-Term Assets	$4.156B	$4.966B	$5.864B
Total Long-Term Assets	$2.731B	$2.163B	$1.537B
Total Assets	$6.888B	$7.129B	$7.402B
YoY Change	12.19%	244.09%	311.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$79.78M	$129.1M	$66.44M
YoY Change	795.01%	823.91%	619.9%
Accrued Expenses	$56.82M	$67.27M	$41.21M
YoY Change	30.45%	87.87%	41.14%
Deferred Revenue
YoY Change
Short-Term Debt	$13.58M	$2.470M	$4.399M
YoY Change	-44.98%	-69.89%
Long-Term Debt Due	$9.780M	$4.657M	$4.485M
YoY Change	199.27%	81.07%	78.69%
Total Short-Term Liabilities	$825.1M	$654.1M	$511.9M
YoY Change	206.27%	31794.82%	97.42%
LONG-TERM LIABILITIES
Long-Term Debt	$1.991B	$1.989B	$1.988B
YoY Change	42370.04%	50094.3%	46743.71%
Other Long-Term Liabilities	$365.0M	$233.7M	$194.9M
YoY Change	99.35%	41.83%	-85.12%
Total Long-Term Liabilities	$2.356B	$2.223B	$2.183B
YoY Change	1186.53%	1217.27%	66.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$825.1M	$654.1M	$511.9M
Total Long-Term Liabilities	$2.356B	$2.223B	$2.183B
Total Liabilities	$3.657B	$3.419B	$3.572B
YoY Change	182.57%	104.23%	127.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.900B	-$6.400B	-$6.100B
YoY Change	38.0%	282.73%
Common Stock	$168.0K	$167.0K	$167.0K
YoY Change	2.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$20.72M	$20.72M
YoY Change
Treasury Stock Shares		857.8K shares	857.8K shares
Shareholders Equity	$3.231B	$3.710B	$3.829B
YoY Change
Total Liabilities & Shareholders Equity	$6.888B	$7.129B	$7.402B
YoY Change	12.19%	244.09%	311.26%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$530.1M	-$220.4M	-$81.29M
YoY Change	1.09%	-15.78%	-89.13%
Depreciation, Depletion And Amortization	$50.65M	$42.45M	$38.24M
YoY Change	239.95%	522.5%	677.43%
Cash From Operating Activities	-$569.5M	-$513.6M	-$494.6M
YoY Change	95.29%	118.49%	126.15%
INVESTING ACTIVITIES
Capital Expenditures	-$290.1M	-$309.8M	-$185.1M
YoY Change	212.64%	177.23%	95.28%
Acquisitions
YoY Change
Other Investing Activities	-$1.085B	-$1.419B
YoY Change		-7469694.74%
Cash From Investing Activities	-$1.375B	-$1.729B	-$185.1M
YoY Change	1381.89%	1447.45%	95.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	17.64M	4.092M	-$187.3M
YoY Change	-99.62%	-95.95%	-136.65%
NET CHANGE
Cash From Operating Activities	-569.5M	-513.6M	-$494.6M
Cash From Investing Activities	-1.375B	-1.729B	-$185.1M
Cash From Financing Activities	17.64M	4.092M	-$187.3M
Net Change In Cash	-1.927B	-2.239B	-$867.0M
YoY Change	-145.44%	810.71%	-538.8%
FREE CASH FLOW
Cash From Operating Activities	-$569.5M	-$513.6M	-$494.6M
Capital Expenditures	-$290.1M	-$309.8M	-$185.1M
Free Cash Flow	-$279.4M	-$203.8M	-$309.6M
YoY Change	40.53%	65.26%	149.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001811210
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39408
	dei	Entity Registrant Name EntityRegistrantName	Lucid Group, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-0891392
	dei	Entity Address Address Line1 EntityAddressAddressLine1	7373 Gateway Boulevard
	dei	Entity Address City Or Town EntityAddressCityOrTown	Newark
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94560
	dei	City Area Code CityAreaCode	510
	dei	Local Phone Number LocalPhoneNumber	648-3553
	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.0001 par value per share
	dei	Trading Symbol TradingSymbol	LCID
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1672806695	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3157449000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6262905000	usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	1136633000	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1294000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3148000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	553045000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	127250000	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	48963000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	70346000	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	69105000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	43328000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	4966489000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	6506977000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1615435000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1182153000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	198207000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	161974000	usd
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	278055000	usd
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	0	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	71233000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	30609000	usd
CY2022Q2	us-gaap	Assets Assets	7129419000	usd
CY2021Q4	us-gaap	Assets Assets	7881713000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	129070000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	41342000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	55550000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	32364000	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4657000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4183000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	464819000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	318212000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	654096000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	396101000	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	5377000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6083000	usd
CY2022Q2	lcid	Common Stock Warrant Liabilities CommonStockWarrantLiabilities	536635000	usd
CY2021Q4	lcid	Common Stock Warrant Liabilities CommonStockWarrantLiabilities	1394808000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1989200000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1986791000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	233725000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	188575000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	3419033000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3972358000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1673401436	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1648413415	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1672543611	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1647555590	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	167000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	165000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10099209000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9995778000	usd
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	857825	shares
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	857825	shares
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	20716000	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	20716000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-691000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6367583000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6065872000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3710386000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3909355000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7129419000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7881713000	usd
CY2022Q2	us-gaap	Revenues Revenues	97336000	usd
CY2021Q2	us-gaap	Revenues Revenues	174000	usd
	us-gaap	Revenues Revenues	155011000	usd
	us-gaap	Revenues Revenues	487000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	292342000	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	19000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	538312000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	104000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	200381000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	176802000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	386457000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	344171000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	163812000	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	72272000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	386971000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	203924000	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	656535000	usd
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	249093000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1311740000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	548199000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-559199000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-248919000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1156729000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-547712000	usd
CY2022Q2	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	0	usd
CY2021Q2	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	12382000	usd
	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	0	usd
	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	454546000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	7189000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	30000	usd
	us-gaap	Interest Expense InterestExpense	14908000	usd
	us-gaap	Interest Expense InterestExpense	35000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	11188000	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-390000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	12144000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-400000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	338842000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-12802000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	855409000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-461957000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-220357000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-261721000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-301320000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1009669000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	68000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	391000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-220425000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-261726000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-301711000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1009678000	usd
CY2022Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2021Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2167332000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-220425000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-261726000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-301711000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3177010000	usd
CY2022Q2	us-gaap	Dilutive Securities DilutiveSecurities	-334843000	usd
CY2021Q2	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
	us-gaap	Dilutive Securities DilutiveSecurities	-858173000	usd
	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-555268000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-261726000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1159884000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3177010000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1669303813	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36298508	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1661960471	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34484767	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1686815404	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36298508	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1684328007	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34484767	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-92.13
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.69
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-92.13
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-691000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-691000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-221116000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-261726000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-302402000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1009678000	usd
CY2022Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2021Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2167332000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-221116000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-261726000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-302402000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3177010000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	3829469000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-220425000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-691000	usd
CY2022Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	8976000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	12882000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3735000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	94392000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3710386000	usd
CY2021Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1088999959	shares
CY2021Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	4454811000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-4227863000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-261726000	usd
CY2021Q2	lcid	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	66909408	shares
CY2021Q2	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	1361273000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	-15719000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	950000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3748000	usd
CY2021Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1155909367	shares
CY2021Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	5836785000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-4469172000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3909355000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-301711000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-691000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	191241000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	12882000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12849000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	268943000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3710386000	usd
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	957159704	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	2494076000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1318777000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1009678000	usd
	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	2151613000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5266000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5630000	usd
CY2021Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1155909367	shares
CY2021Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	5836785000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-4469172000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-301711000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1009678000	usd
	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	80690000	usd
	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	11738000	usd
	lcid	Amortization Of Insurance Premiums AmortizationOfInsurancePremiums	14924000	usd
	lcid	Amortization Of Insurance Premiums AmortizationOfInsurancePremiums	2747000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	8952000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	13502000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	268943000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	129244000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2409000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
	us-gaap	Inventory Write Down InventoryWriteDown	178057000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Equity FairValueAdjustmentOfForwardContractsIndexedToEquity	0	usd
	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Equity FairValueAdjustmentOfForwardContractsIndexedToEquity	-454546000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	5000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-56000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1608000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	220000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	603852000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	27181000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-6459000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	22183000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	32199000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	2380000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	27556000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	3870000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	49596000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-11871000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	23186000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	7990000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-6944000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-7742000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	179544000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	633000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	7795000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	3889000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1008277000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-453804000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	494900000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	206533000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	19000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1419223000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1914123000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-206514000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	15330000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2747000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2401000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1364000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	10950000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	6663000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12849000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5266000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	12882000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	191241000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	6631000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-183209000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	612105000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3105609000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-48213000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6298020000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	640418000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3192411000	usd
	us-gaap	Nature Of Operations NatureOfOperations	DESCRIPTION OF BUSINESS<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lucid Group, Inc. (“Lucid”) is a technology and automotive company focused on designing, developing, manufacturing, and selling the next generation of EV, EV powertrains and battery systems.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lucid was originally incorporated in Delaware on April 30, 2020 under the name Churchill Capital Corp IV (formerly known as Annetta Acquisition Corp) (“Churchill”) as a special purpose acquisition company with the purpose of effecting a merger with one or more operating businesses. On February 22, 2021, Churchill entered into a definitive merger agreement (the “Merger Agreement”) with Atieva, Inc. (“Legacy Lucid”) in which Legacy Lucid would become a wholly owned subsidiary of Churchill (the “Merger”). Upon the closing of the Merger on July 23, 2021 (the “Closing”), Churchill was immediately renamed to “Lucid Group, Inc.” The Merger between Churchill and Legacy Lucid was accounted for as a reverse recapitalization. See Note 3 “Reverse Recapitalization” for more information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the notes to the condensed consolidated financial statements, unless otherwise noted, the “Company,” “we,” “us” or “our” and similar terms refer to Legacy Lucid and its subsidiaries prior to the consummation of the Merger, and Lucid and its subsidiaries after the consummation of the Merger.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company devotes its efforts to business planning, research and development, recruiting of management and technical staff, acquiring operating assets, and raising capital.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From inception through June 30, 2022, the Company has incurred operating losses and negative cash flows from operating activities. For the six months ended June 30, 2022 and 2021, the Company has incurred operating losses, including net losses of $301.7 million and $1,009.7 million, respectively. The Company has an accumulated deficit of $6.4 billion as of June 30, 2022. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended June 30, 2021, the Company completed the first phase of the construction of its newly built manufacturing plant in Casa Grande, Arizona (the “Arizona plant”). The Company began commercial production of its first vehicle, the Lucid Air, in September 2021 and delivered its first vehicles in late October 2021. The Company continues to expand the Arizona plant, start the construction of a manufacturing facility in the Kingdom of Saudi Arabia (the “KSA Facility”), and build a network of retail sales and service locations. The Company has plans for continued development of additional vehicle model types for future release. The aforementioned activities will require considerable capital, above and beyond the expected cash inflows from the initial sales of the Lucid Air. As such, the future operating plan involves considerable risk if secure funding sources are not identified and confirmed.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s existing sources of liquidity include cash, cash equivalents and investments. Historically, the Company funded operations primarily with issuances of convertible preferred stock and convertible notes. Upon the completion of the Merger, the Company received $4,400.3 million in cash proceeds, net of transaction costs. In December 2021, the Company issued an aggregate of $2,012.5 million principal amount of 1.25% convertible senior notes due in December 2026. In addition, during the six months ended June 30, 2022, the Company entered into a loan agreement with the Saudi Industrial Development Fund (“SIDF”) with an aggregate principal amount of up to approximately $1.4 billion, revolving credit facilities with Gulf International Bank (“GIB”) in an aggregate principal amount of approximately $266.5 million and a new five-year senior secured asset-based revolving credit facility (“ABL Credit Facility”) with an initial aggregate principal commitment amount of up to $1.0 billion, See Note 6 “Long-term Debt” for additional information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Significant Risks and Uncertainties</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s current business activities consist of (i) generating sales from the deliveries and service of vehicles, (ii) research and development efforts to design, engineer and develop high-performance fully electric vehicles and advanced electric vehicle powertrain components, including battery pack systems, (iii) production and manufacturing ramps at existing manufacturing facilities in Casa Grande, Arizona, (iv) Phase 2 of construction at Advanced Manufacturing Plant 1 (“AMP-1”) in Casa Grande, Arizona, (v) the start of construction of a manufacturing facility in the Kingdom of Saudi Arabia, and (vi) expansion of our retail studios and service centers capabilities throughout North America and across the globe. The Company is subject to the risks associated with such activities, including the need to further develop its technology, its marketing, and distribution channels; further develop its supply chain and manufacturing; and hire additional management and other key personnel. Successful completion of the Company’s development program and, ultimately, the attainment of profitable operations are dependent upon future events, including our ability to access potential markets, and secure long-term financing.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company participates in a dynamic high-technology industry. Changes in any of the following areas could have a material adverse impact on the Company’s future financial position, results of operations, and/or cash flows: advances and trends in new technologies; competitive pressures; changes in the overall demand for its products and services; acceptance of the Company’s products and services; litigation or claims against the Company based on intellectual property, patent, regulatory, or other factors; and the Company’s ability to attract and retain employees necessary to support its growth.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to impact the global economy and cause significant macroeconomic uncertainty. Infection rates vary across the jurisdictions in which the Company operates. Governmental authorities have continued to implement numerous and constantly evolving measures to attempt to contain the virus, such as travel bans and restrictions, masking recommendations and mandates, vaccine recommendations and mandates, limits on gatherings, quarantines, shelter-in-place orders and business shutdowns. The Company has taken proactive action to protect the health and safety of its employees, customers, partners and suppliers, consistent with the latest and evolving governmental guidelines. Until the COVID-19 pandemic is adequately contained, the Company expects to continue to implement appropriate measures. The Company continues to monitor the rapidly evolving situation and guidance from international and domestic authorities, including federal, state and local public health authorities, and may take additional actions based on their recommendations and requirements or as the Company otherwise sees fit to protect the health and safety of its employees, customers, partners and suppliers.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While certain of the Company and its suppliers’ operations have from time-to-time been temporarily affected by government-mandated restrictions, the Company was able to commence deliveries of the Lucid Air to customers and to proceed with the construction of the Arizona plant. Broader impacts of the pandemic have included inflationary pressure as well as ongoing, industry-wide challenges in logistics and supply chains, such as increased port congestion, intermittent supplier delays and a shortfall of semiconductor supply. Because the Company relies on third party suppliers for the development, manufacture, and/or provision and development of many of the key components and materials used in its vehicles, as well as provisioning and servicing equipment in its manufacturing facilities, the Company has been affected by inflation and such industry-wide challenges in logistics and supply chains. While the Company continues to focus on mitigating risks to its operations and supply chain in the current industry environment, the Company expects that these industry-wide trends will continue to impact its cost structure as well as its ability and the ability of its suppliers to obtain parts, components and manufacturing equipment on a timely basis for the foreseeable future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the current circumstances, given the dynamic nature of the situation, any impact on the Company’s financial condition, results of operations or cash flows in the future continues to be difficult to estimate and predict, as it depends on future events that are highly uncertain and cannot be predicted with accuracy, including, but not limited to, the duration and continued spread of the outbreak, its severity, potential additional waves of infection, the emergence of more virulent or more dangerous strains of the virus, the actions taken to mitigate the virus or its impact, the development, distribution, efficacy and acceptance of vaccines worldwide, how quickly and to what extent normal economic and operating conditions can resume, the broader impact that the pandemic is having on the economy and our industry and specific implications the pandemic may have on the Company’s suppliers and on global logistics. See “Risk Factors” in Part II, Item 1A of this </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quarterly Report </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on Form 10-Q (the “Quarterly Report”) for additional information regarding risks associated with the COVID-19 pandemic, including under the caption “The ongoing COVID-19 pandemic has adversely affected, and we cannot predict its ultimate impact on, our business, results of operations and financial condition.”</span></div>
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	592205000	usd
	us-gaap	Interest Paid Net InterestPaidNet	12282000	usd
	us-gaap	Interest Paid Net InterestPaidNet	198000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	480000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	lcid	Change In Capital Expenditures Incurred But Not Yet Paid ChangeInCapitalExpendituresIncurredButNotYetPaid	17240000	usd
	lcid	Change In Capital Expenditures Incurred But Not Yet Paid ChangeInCapitalExpendituresIncurredButNotYetPaid	-24661000	usd
	lcid	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability	47022000	usd
	lcid	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability	4437000	usd
	lcid	Issuance Of Convertible Preferred Stock Upon Exercise Of Preferred Stock Warrants IssuanceOfConvertiblePreferredStockUponExerciseOfPreferredStockWarrants	0	usd
	lcid	Issuance Of Convertible Preferred Stock Upon Exercise Of Preferred Stock Warrants IssuanceOfConvertiblePreferredStockUponExerciseOfPreferredStockWarrants	9936000	usd
	lcid	Issuance Of Convertible Preferred Share Contingent Forward Contracts IssuanceOfConvertiblePreferredShareContingentForwardContracts	0	usd
	lcid	Issuance Of Convertible Preferred Share Contingent Forward Contracts IssuanceOfConvertiblePreferredShareContingentForwardContracts	2167332000	usd
	lcid	Capital Contribution Upon Issuance Of Preferred Shares CapitalContributionUponIssuanceOfPreferredShares	0	usd
	lcid	Capital Contribution Upon Issuance Of Preferred Shares CapitalContributionUponIssuanceOfPreferredShares	15719000	usd
	lcid	Capital Leases Retired Upon Adoption Of New Lease Accounting Standard CapitalLeasesRetiredUponAdoptionOfNewLeaseAccountingStandard	0	usd
	lcid	Capital Leases Retired Upon Adoption Of New Lease Accounting Standard CapitalLeasesRetiredUponAdoptionOfNewLeaseAccountingStandard	3257000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-301700000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1009700000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6400000000	usd
CY2021Q3	lcid	Proceeds From Reverse Recapitalization Net Of Transaction Costs ProceedsFromReverseRecapitalizationNetOfTransactionCosts	4400300000	usd
CY2021Q3	lcid	Proceeds From Reverse Recapitalization Net Of Transaction Costs ProceedsFromReverseRecapitalizationNetOfTransactionCosts	4400300000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Significant estimates, assumptions and judgments made by management include, among others, inventory valuation, warranty reserve, the determination of the useful lives of property and equipment, fair value of preferred stock warrants, fair value of common stock warrants, fair value of contingent forward contracts liability, valuation of deferred income tax assets and uncertain tax positions, fair value of common stock and other assumptions used to measure stock-based compensation expense, and estimated incremental borrowing rates for assessing operating and financing lease liabilities. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods.</span></div>
CY2022Q2	us-gaap	Cash Cash	3157449000	usd
CY2021Q4	us-gaap	Cash Cash	6262905000	usd
CY2021Q2	us-gaap	Cash Cash	557938000	usd
CY2020Q4	us-gaap	Cash Cash	614412000	usd
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	4039000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	10740000	usd
CY2021Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	10989000	usd
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	11278000	usd
CY2022Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	30923000	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	24375000	usd
CY2021Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	23278000	usd
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	14728000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3192411000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6298020000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	592205000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	640418000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash, cash equivalents, and investments. The Company places its cash primarily with domestic financial institutions that are federally insured within statutory limits, but at times its deposits may exceed federally insured limits.</span></div>
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	451295965	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	451295965	shares
CY2021Q3	lcid	Reverse Recapitalization Conversion Price ReverseRecapitalizationConversionPrice	10.00
CY2021Q3	lcid	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	2.644
CY2021Q3	lcid	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments And Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsAndOptionsOutstandingNumber	42182931	shares
CY2021Q3	lcid	Share Based Payment Award Equity Instruments And Options Converted Reverse Recapitalization ShareBasedPaymentAwardEquityInstrumentsAndOptionsConvertedReverseRecapitalization	111531080	shares
CY2021Q3	lcid	Reverse Recapitalization Conversion Price ReverseRecapitalizationConversionPrice	10.00
CY2021Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	437182072	shares
CY2021Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	437182072	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	451295965	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	451295965	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	25764610	shares
CY2021Q3	lcid	Share Based Payment Award Options Converted ShareBasedPaymentAwardOptionsConverted	68121210	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	16418321	shares
CY2021Q3	lcid	Share Based Payment Award Non Option Equity Instruments Converted Reverse Recapitalization ShareBasedPaymentAwardNonOptionEquityInstrumentsConvertedReverseRecapitalization	43409870	shares
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2500000000	usd
CY2021Q3	lcid	Reverse Recapitalization Working Capital Loan Converted Amount ReverseRecapitalizationWorkingCapitalLoanConvertedAmount	1500000	usd
CY2021Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1500000	shares
CY2021Q3	lcid	Debt Conversion Converted Instrument Warrants Or Options Issued Price Per Warrant DebtConversionConvertedInstrumentWarrantsOrOptionsIssuedPricePerWarrant	1.00
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Shares ReverseRecapitalizationContingentConsiderationShares	17250000	shares
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Warrants ReverseRecapitalizationContingentConsiderationWarrants	14783333	shares
CY2021Q3	lcid	Reverse Recapitalization Conversion Price ReverseRecapitalizationConversionPrice	10.00
CY2021Q3	lcid	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	425395023	shares
CY2021Q3	lcid	Stock Converted Reverse Recapitalization StockConvertedReverseRecapitalization	1193226511	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1618621534	shares
CY2021Q3	lcid	Share Based Payment Award Equity Instruments And Options Converted Reverse Recapitalization ShareBasedPaymentAwardEquityInstrumentsAndOptionsConvertedReverseRecapitalization	111531080	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	85750000	shares
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Warrants ReverseRecapitalizationContingentConsiderationWarrants	14783333	shares
CY2021Q3	lcid	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	4439200000	usd
CY2021Q3	lcid	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	2070100000	usd
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2500000000	usd
CY2021Q3	us-gaap	Cash Cash	400000	usd
CY2021Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	200000	usd
CY2021Q3	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	21644	shares
CY2021Q3	lcid	Reverse Recapitalization Transaction Costs Incurred ReverseRecapitalizationTransactionCostsIncurred	38900000	usd
CY2021Q3	lcid	Adjustments To Additional Paid In Capital Reduction For Reverse Recapitalization Transaction Costs AdjustmentsToAdditionalPaidInCapitalReductionForReverseRecapitalizationTransactionCosts	36200000	usd
CY2021Q3	lcid	Reverse Recapitalization Transaction Costs Expensed ReverseRecapitalizationTransactionCostsExpensed	2700000	usd
CY2021Q3	lcid	Proceeds From Reverse Recapitalization Net Of Transaction Costs ProceedsFromReverseRecapitalizationNetOfTransactionCosts	4400300000	usd
CY2021Q3	lcid	Proceeds From Reverse Recapitalization Net Of Transaction Costs ProceedsFromReverseRecapitalizationNetOfTransactionCosts	4400300000	usd
CY2022Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	400109000	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	87646000	usd
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	103721000	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	30641000	usd
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	49215000	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8963000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	553045000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	127250000	usd
CY2022Q2	us-gaap	Inventory Write Down InventoryWriteDown	81700000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	178100000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2021Q2	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	1781938000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	1268166000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	166503000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	86013000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1615435000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1182153000	usd
CY2022Q2	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	42500000	usd
	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	80700000	usd
CY2021Q2	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	6800000	usd
	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	11700000	usd
CY2022Q2	lcid	Engineering Design And Testing Liability Current EngineeringDesignAndTestingLiabilityCurrent	21946000	usd
CY2021Q4	lcid	Engineering Design And Testing Liability Current EngineeringDesignAndTestingLiabilityCurrent	33950000	usd
CY2022Q2	us-gaap	Construction Payable Current ConstructionPayableCurrent	110405000	usd
CY2021Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	92590000	usd
CY2022Q2	lcid	Accrued Unbilled Inventory Purchases AccruedUnbilledInventoryPurchases	145654000	usd
CY2021Q4	lcid	Accrued Unbilled Inventory Purchases AccruedUnbilledInventoryPurchases	12225000	usd
CY2022Q2	lcid	Tenant Improvement Liability Current TenantImprovementLiabilityCurrent	14127000	usd
CY2021Q4	lcid	Tenant Improvement Liability Current TenantImprovementLiabilityCurrent	15796000	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	32064000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	13944000	usd
CY2022Q2	lcid	Tooling Liability Current ToolingLiabilityCurrent	12225000	usd
CY2021Q4	lcid	Tooling Liability Current ToolingLiabilityCurrent	23966000	usd
CY2022Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	2470000	usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	15281000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11721000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11056000	usd
CY2022Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	114207000	usd
CY2021Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	99404000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	464819000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	318212000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	1137726000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	222457000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	185323000	usd
CY2022Q2	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	11268000	usd
CY2021Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	3252000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	233725000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	188575000	usd
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	4200000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	0	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	1136633000	usd
CY2022Q2	lcid	Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year One Through Three DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree	277646000	usd
CY2022Q2	lcid	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year One Through Three DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree	278055000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	1415372000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	1414688000	usd
CY2021Q2	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	12400000	usd
	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	454500000	usd
CY2021Q2	us-gaap	Share Price SharePrice	23.78
CY2017Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2	shares
CY2017Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1546799	shares
CY2017Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.94
CY2021Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.94
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3000000	usd
CY2021Q1	lcid	Temporary Equity Stock Issued During Period Value Warrant Exercises TemporaryEquityStockIssuedDuringPeriodValueWarrantExercises	12900000	usd
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants ReverseRecapitalizationContingentConsiderationWarrants	14783333	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants ReverseRecapitalizationContingentConsiderationWarrants	14783333	shares
CY2022Q2	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2020Q3	lcid	Number Of Milestone Conditions Required To Receive Funding NumberOfMilestoneConditionsRequiredToReceiveFunding	2	condition
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1316758889	shares
CY2021Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	1155909398	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	lcid	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	425395023	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1618621534	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	lcid	Common Stock Voting Rights Number Of Votes Allowed For Each Share CommonStockVotingRightsNumberOfVotesAllowedForEachShare	1	vote
CY2022Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021	lcid	Class Of Warrant Or Right Number Of Warrants Exercised ClassOfWarrantOrRightNumberOfWarrantsExercised	41034197	shares
CY2021	lcid	Class Of Warrant Or Right Number Of Warrants Exercised In Noncash Transaction ClassOfWarrantOrRightNumberOfWarrantsExercisedInNoncashTransaction	25966976	shares
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	173300000	usd
CY2021	lcid	Class Of Warrant Or Right Warrants Redeemed Or Called During Period Shares ClassOfWarrantOrRightWarrantsRedeemedOrCalledDuringPeriodShares	365803	shares
CY2021Q4	lcid	Class Of Warrant Or Right Redemption Price ClassOfWarrantOrRightRedemptionPrice	0.01
CY2021	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	857825	shares
CY2021	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	24.15
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2022Q2	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2021Q2	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2022Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	201076230	shares
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	210204258	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Contingency Period ReverseRecapitalizationContingentConsiderationContingencyPeriod	P5Y
CY2021	lcid	Reverse Recapitalization Contingent Consideration Shares Vested ReverseRecapitalizationContingentConsiderationSharesVested	17250000	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants Vested ReverseRecapitalizationContingentConsiderationWarrantsVested	14783333	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants Target Share Price Threshold Trading Days ReverseRecapitalizationContingentConsiderationWarrantsTargetSharePriceThresholdTradingDays	40	day
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants Target Share Price Threshold Consecutive Trading Days ReverseRecapitalizationContingentConsiderationWarrantsTargetSharePriceThresholdConsecutiveTradingDays	60	day
CY2021	lcid	Reverse Recapitalization Contingent Consideration Shares Vested ReverseRecapitalizationContingentConsiderationSharesVested	17250000	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants Vested ReverseRecapitalizationContingentConsiderationWarrantsVested	14783333	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	64119902	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.08
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y7M6D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2370666000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	16195326	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.79
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1655679	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.85
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	46268897	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.15
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10M2D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	742613000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	31731833	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.93
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y3M3D
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	515722000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	48234611	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	11441063	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	16550572	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	1150078	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	41975024	shares
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	94392000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	129244000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24449000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	268943000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	198207000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	161974000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11721000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11056000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	222457000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	185323000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	234178000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	196379000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	10368000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	10567000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	10368000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	10567000	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4657000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4183000	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	5377000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6083000	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	10034000	usd
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	10266000	usd
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	10749000	usd
CY2021Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	7219000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	20327000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	13522000	usd
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	897000	usd
CY2021Q2	us-gaap	Variable Lease Cost VariableLeaseCost	579000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	1675000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	1159000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1133000	usd
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	637000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2229000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1232000	usd
CY2022Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	144000	usd
CY2021Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	104000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	289000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	213000	usd
CY2022Q2	lcid	Finance Lease Cost FinanceLeaseCost	1277000	usd
CY2021Q2	lcid	Finance Lease Cost FinanceLeaseCost	741000	usd
	lcid	Finance Lease Cost FinanceLeaseCost	2518000	usd
	lcid	Finance Lease Cost FinanceLeaseCost	1445000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	12923000	usd
CY2021Q2	us-gaap	Lease Cost LeaseCost	8539000	usd
	us-gaap	Lease Cost LeaseCost	24520000	usd
	us-gaap	Lease Cost LeaseCost	16126000	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y9M18D
CY2022Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1046
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1098
CY2022Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0574
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0558
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	46606000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	12763000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	2544000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	4782000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	47121000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	2185000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	46401000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	674000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	42846000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	457000	usd
CY2022Q2	lcid	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	165176000	usd
CY2022Q2	lcid	Finance Lease Liability Payments Due After Year Four FinanceLeaseLiabilityPaymentsDueAfterYearFour	115000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	360913000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	10757000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	126735000	usd
CY2022Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	723000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11721000	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4657000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	234178000	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	10034000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	222457000	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	5377000	usd
CY2022Q2	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	31500000	usd
CY2022Q2	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	42900000	usd
CY2022Q2	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	49800000	usd
CY2022Q2	us-gaap	Purchase Obligation PurchaseObligation	124200000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	68000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	391000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9000	usd
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.000
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.000
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-220425000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-261726000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-301711000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1009678000	usd
CY2022Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2021Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2167332000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-220425000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-261726000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-301711000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3177010000	usd
CY2022Q2	us-gaap	Dilutive Securities DilutiveSecurities	-334843000	usd
CY2021Q2	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
	us-gaap	Dilutive Securities DilutiveSecurities	-858173000	usd
	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-555268000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-261726000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1159884000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3177010000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1669303813	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36298508	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1661960471	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34484767	shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	17511591	shares
CY2021Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	22367536	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1686815404	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36298508	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1684328007	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34484767	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-92.13
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.69
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-92.13
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1681545859	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	127373846	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1266594964	shares
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	usd
CY2021Q2	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	usd
CY2022Q2	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	usd

Files In Submission

Name	View Source	Status
0001628280-22-020609-index-headers.html	Edgar Link	pending
0001628280-22-020609-index.html	Edgar Link	pending
0001628280-22-020609.txt	Edgar Link	pending
0001628280-22-020609-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lcid-20220630.htm	Edgar Link	pending
lcid-20220630.xsd	Edgar Link	pending
lcid-20220630_cal.xml	Edgar Link	unprocessable
lcid-20220630_def.xml	Edgar Link	unprocessable
lcid-20220630_htm.xml	Edgar Link	completed
lcid-20220630_lab.xml	Edgar Link	unprocessable
lcid-20220630_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
q22210q-ex102.htm	Edgar Link	pending
q22210q-ex311.htm	Edgar Link	pending
q22210q-ex312.htm	Edgar Link	pending
q22210q-ex321.htm	Edgar Link	pending
q22210q-ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LCID
Lucid Group, Inc. Stock $lcid

2022 Q3 Form 10-Q Financial Statement

#000162828022020609 Filed on August 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LCID Lucid Group, Inc. Stock $lcid

2022 Q3 Form 10-Q Financial Statement

#000162828022020609 Filed on August 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LCID
Lucid Group, Inc. Stock $lcid